Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

NCT03601975 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Gemcitabine/Cisplatin

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.